Skip to main content

Table 2 Clinical and demographic characteristics of participants in the validation study

From: Development and psychometric properties of the Suicidality: Treatment Occurring in Paediatrics (STOP) Suicidality Assessment Scale (STOP-SAS) in children and adolescents

Participants Adolescents
n = 576 (%)a
Children
n = 187 (%)a
Diagnoses DSM-IV-TR*
 Eating disorder 65 (6.1) 0
 Major Depressive Disorder (MDD) 258 (24) 16 (3.9)
 Attention Deficit Hyperactivity Disorder (ADHD) 153 (14.3) 127 (30.6)
 Conduct Disorder/Oppositional Defiant Disorder (CD/ODD) 89 (8.3) 60 (14.5)
 Bipolar Disorder 39 (3.6) 6 (1.4)
 Schizophrenia and Other Psychotic Disorders 36 (3.4) 0
 Anxiety Disorders 129 (12) 35 (8.4)
 Pervasive Developmental Disorders 114 (10.6) 67 (16.1)
 Tic Disorders 25 (2.3) 13 (3.1)
 Substance Related Disorders 14 (1.3) 0
 Mental Retardation 55 (5.1) 35 (8.4)
 Learning Disorders 20 (1.9) 12 (2.9)
 Other Disorders 76 (7.1) 44 (10.6)
Pharmacological treatment
 Antipsychotics 367 (41) 143 (48)
 Antidepressants 265 (29.6) 22 (7.4)
 Stimulants 60 (6.7) 68 (22.8)
 Mood stabilizers and Lithium 46 (5.1) 10 (3.4)
 Benzodiazepines 36 (4) 1 (0.3)
 Other psychiatric pharmacological treatments 56 (6.3) 35 (11.7)
 Non-psychiatric pharmacological treatments 64 (7.1) 19 (6.6)
 No pharmacological treatment 68 (11.08)b 19 (10.16)b
  1. * DSM-IV-TR = The Diagnostic and Statistical Manual of Mental Disorders. Fourth edition, text revised
  2. a Percentage considering the total number of medications and diagnoses
  3. b Number of patients and percentage considering total number of patients